metastatic pancreatic endocrine carcinoma

DBCOND0022757Digestive System DiseasesEndocrine System Diseases

metastatic pancreatic endocrine carcinoma is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Metastatic Pancreatic Carcinoma · Pancreatic Carcinoma Metastatic
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT459401000124106MedDRA10033610UMLSC0854775

What you can answer from here — as of November 01, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
25Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for metastatic pancreatic endocrine carcinoma share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In